Objective Conflicting data have led to controversy regarding antidepressant use during
pregnancy. The objectives of this study are to i) review the risks of untreated depression and …

Diversas questões ainda estão em aberto no que se refere a um tema tão amplo quanto a
saúde mental das mulheres em período de gestação e puerpério. Por mais contraditório …

BACKGROUND: Maternal use of selective serotonin re‐uptake inhibitors (SSRIs) has
recently been associated with an increased risk for certain malformations. METHODS: Using …

Introduction Antidepressant use during the first trimester is reported in 4–8% of pregnancies.
The use of some selective serotonin reuptake inhibitors during the first trimester has been …

Aims The aim of this study was to perform an up‐to‐date meta‐analysis on the risk of cardiac
malformations associated with gestational exposure to paroxetine, taking into account …

Background: An increasing number of studies have reported differences in the
pharmacokinetics and/or pharmacodynamics of antidepressants between women and men …

Objective The aim of this study was to determine the extent and patterns of antidepressant
use before, during and after pregnancy in a large population in The Netherlands. Methods …

Purpose To refine a preliminary analysis identifying a possibly increased prevalence of
malformations among infants born to women exposed to paroxetine in the first trimester …

Abstract Purpose Reports from the GlaxoSmithKline Bupropion Pregnancy Registry
suggested an increase in cardiovascular defects following exposure to bupropion during …

This literature review and the recommendations therein were prepared for the American
Gastroenterological Association Institute Clinical Practice and Economics Committee. The …